A CHECKPOINT INHIBITOR AND A WHOLE CELL MYCOBACTERIUM FOR USE IN CANCER THERAPY

• 收藏
• 分享

专利权人:

Immodulon Therapeutics Limited

发明人:

Akle, Charles,Grange, John,Bilyard, Kevin

申请号：

AU2020201754

公开号：

AU2020201754A1

申请日:

2020.03.10

申请国别(地区):

AU

年份:

2020

代理人:

摘要：

#$%^&*AU2020201754A120200326.pdf#####Abstract An immunomodulator for use in the treatment, reduction, inhibition or control of a neoplastic disease in a patient intended to undergo checkpoint inhibition therapy, 5 simultaneously, separately or sequentially with administration of the immunomodulator. The immunomodulator preferably comprises a whole cell Mycobacterium, for example, M. vaccae or M. obuense.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/